-transparent.png){kind=logo}
Fendiline was administered intravenously (3 mg) and orally (50 mg and 75 mg) in a cross-over study to six healthy volunteers. The plasma levels of unchanged fendiline and of total radioactivity were measured. Fendiline was absorbed well and its concentration declined biexponentially with mean terminal half-lives of 20-35 h. Since the drug is extensively metabolized, only 12% of total radioactivity in plasma corresponded to fendiline in the case of intravenous administration as compared to less than 2% after oral administration. 56-65% of the administered dose are excreted via the urine and 18-25% with the feces within five days.
Related Publications
W R Kukovetz, and
F Brunner, and
E Beubler, and
R Weyhenmeyer, and
R Lohaus, and
M Grob, and
D Mayer
June 1986,
Journal of pharmaceutical sciences,
W R Kukovetz, and
F Brunner, and
E Beubler, and
R Weyhenmeyer, and
R Lohaus, and
M Grob, and
D Mayer
February 1984,
Journal of chromatography,
W R Kukovetz, and
F Brunner, and
E Beubler, and
R Weyhenmeyer, and
R Lohaus, and
M Grob, and
D Mayer
February 1993,
Antimicrobial agents and chemotherapy,
W R Kukovetz, and
F Brunner, and
E Beubler, and
R Weyhenmeyer, and
R Lohaus, and
M Grob, and
D Mayer
January 1986,
European journal of drug metabolism and pharmacokinetics,
W R Kukovetz, and
F Brunner, and
E Beubler, and
R Weyhenmeyer, and
R Lohaus, and
M Grob, and
D Mayer
January 1989,
Biopharmaceutics & drug disposition,
W R Kukovetz, and
F Brunner, and
E Beubler, and
R Weyhenmeyer, and
R Lohaus, and
M Grob, and
D Mayer
January 1986,
European journal of drug metabolism and pharmacokinetics,
W R Kukovetz, and
F Brunner, and
E Beubler, and
R Weyhenmeyer, and
R Lohaus, and
M Grob, and
D Mayer
July 1985,
Pharmacopsychiatry,
W R Kukovetz, and
F Brunner, and
E Beubler, and
R Weyhenmeyer, and
R Lohaus, and
M Grob, and
D Mayer
November 1991,
Biopharmaceutics & drug disposition,
W R Kukovetz, and
F Brunner, and
E Beubler, and
R Weyhenmeyer, and
R Lohaus, and
M Grob, and
D Mayer
January 1987,
Arzneimittel-Forschung,
W R Kukovetz, and
F Brunner, and
E Beubler, and
R Weyhenmeyer, and
R Lohaus, and
M Grob, and
D Mayer
February 1986,
Journal of pharmaceutical sciences,
